CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD.
about
Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's diseaseOmega 3 fatty acids (fish oil) for maintenance of remission in Crohn's diseaseOmega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitisModeling-Enabled Systems Nutritional ImmunologyNutritional protective mechanisms against gut inflammationDietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γImmunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteriaEffects of fish oil and conjugated linoleic acids on expression of target genes of PPAR alpha and sterol regulatory element-binding proteins in the liver of laying hens.Modeling the role of peroxisome proliferator-activated receptor γ and microRNA-146 in mucosal immune responses to Clostridium difficile.Interleukin-6 and Cyclooxygenase-2 downregulation by fatty-acid fractions of Ranunculus constantinopolitanusImmunoregulatory actions of epithelial cell PPAR gamma at the colonic mucosa of mice with experimental inflammatory bowel disease.Deciphering the porcine intestinal microRNA transcriptome.The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease.Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma.Early Gut Microbiota Intervention Suppresses DSS-Induced Inflammatory Responses by Deactivating TLR/NLR Signalling in Pigs.Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitisMaintenance of remission in inflammatory bowel disease using omega-3 fatty acids (fish oil): a systematic review and meta-analyses.Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel disease.Polyunsaturated fatty acids modify expression of TGF-β in a co-culture model ultilising human colorectal cells and human peripheral blood mononuclear cells exposed to Lactobacillus gasseri, Escherichia coli and Staphylococcus aureus.Resistant starch induces catabolic but suppresses immune and cell division pathways and changes the microbiome in the proximal colon of male pigs.Pharmacophore modeling improves virtual screening for novel peroxisome proliferator-activated receptor-gamma ligands.Emerging significance of NLRs in inflammatory bowel disease.Lipophilic compound-mediated gene expression and implication for intervention in reactive oxygen species (ROS)-related diseases: mini-reviewA hexane fraction of American ginseng suppresses mouse colitis and associated colon cancer: anti-inflammatory and proapoptotic mechanisms.Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARδ in inflammation-induced colon carcinogenesis.Fatty acids, inflammation and intestinal health in pigs.Pomegranate seed oil reduces intestinal damage in a rat model of necrotizing enterocolitis.Effects of conjugated linoleic acid and high oleic acid safflower oil in the treatment of children with HPV-induced laryngeal papillomatosis: a randomized, double-blinded and crossover preliminary study.Dextran sulfate inhibits acute Toxoplama gondii infection in pigsConjugated linoleic acid modulation of risk factors associated with atherosclerosisEffects of increase in fish oil intake on intestinal eicosanoids and inflammation in a mouse model of colitisDietary modulation of inflammation-induced colorectal cancer through PPARγ.The effect of trans-10, cis-12 conjugated linoleic acid on gene expression profiles related to lipid metabolism in human intestinal-like Caco-2 cells.Intestinal PPARγ signalling is required for sympathetic nervous system activation in response to caloric restriction.Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease.Nutritional considerations in pediatric inflammatory bowel disease.New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin.Intestinal gene expression in pigs: effects of reduced feed intake during weaning and potential impact of dietary components.Nutritional and probiotic supplementation in colitis models.Bioactive dietary peptides and amino acids in inflammatory bowel disease.
P2860
Q24200184-CE2BB0AB-6E3B-4C93-A9C4-080C250999A5Q24241348-2E3D15C6-F632-4282-9CD5-6210987F1DBFQ24244006-72A0B289-F38F-4E00-A322-9C3CE2FDF0A6Q26766623-24FF331F-BE47-4C18-8A43-078B50543948Q27028202-4E07014E-C6EE-43E0-9620-EC2F93DE059AQ28476741-6AAF74A4-3C6E-4049-9EE3-E97769E3B247Q28730618-F89D79B1-21A8-4FB5-9015-F23D3AB59874Q30319689-EE31E63F-92D8-437A-B146-B6E474B1B0B2Q30424551-9286191D-0C75-4166-8343-ED98AC8B28F6Q30886740-1CA09A0E-01BF-4F1F-9899-8334B5944150Q33565689-7535581F-0E84-4420-B299-5BACE3DEEEDBQ33569209-C8F649EC-1C0D-458A-A795-8AB2F031184DQ33600282-D4E87264-4D50-43B7-B5BA-89ED11E27FBCQ33652897-4FE2A025-4DA7-419F-9A91-80BEB1979613Q33789614-32525107-CDCE-4365-970E-053BF2CC0B9AQ34170678-F3066EFE-5760-402D-A599-05E7680163FBQ34620794-9283CB8C-FCAF-4613-8712-0D4CE5BE7D36Q34626425-E0E9B910-8BBB-4327-A9DB-FDD181799B1CQ34802933-38CC1537-9840-4072-B9B8-7F7F099AF359Q35019426-0F6BEE83-0744-4F59-BF44-377D3F8588B5Q35395528-05152FB4-4AD7-46B5-80A3-899BD6FA9963Q35414220-5D5B6579-3B48-4BF6-A4F8-8C46FDBA5642Q35671000-B216D27E-32DB-4F76-A671-99C00C57333FQ35884147-E3A46C1E-3BF6-4E75-8B53-7415FD704E46Q35939357-ABEB9741-579D-4BA8-B6A5-5C225BF0EF59Q36045305-999A67B0-6083-46D9-AA9D-4879BB96C3E1Q36309520-61971C01-DF86-4BB4-A40A-164D78DCE7F4Q36552179-5D567054-9E6C-4312-9139-7FFF268B869EQ36668209-463FA26C-6988-45E0-9196-DC441ABD64D9Q36897274-E5C6B922-3D2D-449F-A281-23248B3226EBQ36953369-F17B2730-4742-4DDF-B93F-9D47EFEF4B45Q37166674-1B0D57EF-B518-45CE-8368-748B5E55F97EQ37213112-21144DE7-B0BA-4EBC-B6DC-E28DA9C514EFQ37419913-30158E79-99FC-48CF-881A-8F2FACB85328Q37761288-16B83237-989D-4907-931F-CAAC32158538Q37763081-7762A672-C06D-4A05-86EC-103B9B4DEFB8Q37900677-0F187FBC-9EA6-4C9C-842F-BDBD271D9F52Q37931436-68FCA70C-B059-41C2-AD93-27A9D3F24897Q38021933-8E4F2107-3549-4F19-975E-9ABFE5D32B43Q38287022-DDEA4EF5-5E9F-48D8-8111-8ECBFADABDAF
P2860
CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBD.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
CLA and n-3 PUFA differentiall ...... pig model of experimental IBD.
@ast
CLA and n-3 PUFA differentiall ...... pig model of experimental IBD.
@en
CLA and n-3 PUFA differentiall ...... pig model of experimental IBD.
@nl
type
label
CLA and n-3 PUFA differentiall ...... pig model of experimental IBD.
@ast
CLA and n-3 PUFA differentiall ...... pig model of experimental IBD.
@en
CLA and n-3 PUFA differentiall ...... pig model of experimental IBD.
@nl
prefLabel
CLA and n-3 PUFA differentiall ...... pig model of experimental IBD.
@ast
CLA and n-3 PUFA differentiall ...... pig model of experimental IBD.
@en
CLA and n-3 PUFA differentiall ...... pig model of experimental IBD.
@nl
P1433
P1476
CLA and n-3 PUFA differentiall ...... pig model of experimental IBD.
@en
P304
P356
10.1016/J.CLNU.2005.12.008
P577
2006-05-15T00:00:00Z